▶ 調査レポート

レボノルゲストレルの世界市場レポート2020

• 英文タイトル:Global Levonorgestrel Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。レボノルゲストレルの世界市場レポート2020 / Global Levonorgestrel Sales Market Report 2020 / 20QY06-04387資料のイメージです。• レポートコード:20QY06-04387
• 出版社/出版日:QYResearch / 2020年6月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、135ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、レボノルゲストレルのグローバル市場について種類別(レボノルゲストレル錠剤、混合製品、ホルモン放出IUD)、用途別(病院、ドラッグストア、オンライン販売)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・レボノルゲストレル市場の概要
・世界の主要地域別レボノルゲストレル市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のレボノルゲストレル市場規模2015-2026:種類別(レボノルゲストレル錠剤、混合製品、ホルモン放出IUD)
・世界のレボノルゲストレル市場規模2015-2026:用途別(病院、ドラッグストア、オンライン販売)
・レボノルゲストレルの北米市場規模2015-2020
・レボノルゲストレルのヨーロッパ市場規模2015-2020
・レボノルゲストレルの中国市場規模2015-2020
・レボノルゲストレルの日本市場規模2015-2020
・レボノルゲストレルの東南アジア市場規模2015-2020
・レボノルゲストレルのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Bayer、Paladin Labs、Foundation Consumer Healthcare、Theramex (Teva)、Pfizer、Apotex、HRA Pharma)
・レボノルゲストレルの製造コスト分析
・販売チャネル、流通業者、顧客
・レボノルゲストレルの市場動向・機会・課題
・調査の結論

Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantable form of levonorgestrel is also available in some countries.
Levonorgestrel is widely sales through Hospital, Drug Store and Online Sale. The most proportion of Levonorgestrel is sales through Drug Store, and the proportion is about 73%.

Market Analysis and Insights: Global Levonorgestrel Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Levonorgestrel market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Levonorgestrel industry.
Based on our recent survey, we have several different scenarios about the Levonorgestrel YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Levonorgestrel will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Global Levonorgestrel Scope and Market Size
The global Levonorgestrel market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Levonorgestrel market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Levonorgestrel market is segmented into
Levonorgestrel Table
Mixture Products
Hormone-releasing IUD

Segment by Application, the Levonorgestrel market is segmented into
Hospital
Drug Store
Online Sale

The Levonorgestrel market is analysed and market size information is provided by regions (countries). Segment by Application, the Levonorgestrel market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Levonorgestrel Market Share Analysis
Levonorgestrel market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Levonorgestrel business, the date to enter into the Levonorgestrel market, Levonorgestrel product introduction, recent developments, etc.

The major vendors covered:
Bayer
Paladin Labs
Foundation Consumer Healthcare
Theramex (Teva)
Pfizer
Apotex
HRA Pharma

レポート目次

1 Levonorgestrel Market Overview
1.1 Levonorgestrel Product Scope
1.2 Levonorgestrel Segment by Type
1.2.1 Global Levonorgestrel Sales by Type (2020-2026)
1.2.2 Levonorgestrel Table
1.2.3 Mixture Products
1.2.4 Hormone-releasing IUD
1.3 Levonorgestrel Segment by Application
1.3.1 Global Levonorgestrel Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Online Sale
1.4 Levonorgestrel Market Estimates and Forecasts (2015-2026)
1.4.1 Global Levonorgestrel Sales Growth Rate (2015-2026)
1.4.2 Global Levonorgestrel Revenue and Growth Rate (2015-2026)
1.4.3 Global Levonorgestrel Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Levonorgestrel Industry Impact
1.5.1 How the Covid-19 is Affecting the Levonorgestrel Industry
1.5.1.1 Levonorgestrel Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Levonorgestrel Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Levonorgestrel Players to Combat Covid-19 Impact

2 Levonorgestrel Estimate and Forecast by Region
2.1 Global Levonorgestrel Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Levonorgestrel Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Levonorgestrel Sales Market Share by Region (2015-2020)
2.2.2 Global Levonorgestrel Revenue Market Share by Region (2015-2020)
2.3 Global Levonorgestrel Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Levonorgestrel Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Levonorgestrel Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Levonorgestrel Estimates and Projections (2015-2026)
2.4.2 Europe Levonorgestrel Estimates and Projections (2015-2026)
2.4.3 China Levonorgestrel Estimates and Projections (2015-2026)
2.4.4 Japan Levonorgestrel Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Levonorgestrel Estimates and Projections (2015-2026)
2.4.6 India Levonorgestrel Estimates and Projections (2015-2026)
3 Global Levonorgestrel Competition Landscape by Players
3.1 Global Top Levonorgestrel Players by Sales (2015-2020)
3.2 Global Top Levonorgestrel Players by Revenue (2015-2020)
3.3 Global Levonorgestrel Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Levonorgestrel as of 2019)
3.4 Global Levonorgestrel Average Price by Company (2015-2020)
3.5 Manufacturers Levonorgestrel Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Levonorgestrel Players (Opinion Leaders)
4 Global Levonorgestrel Market Size by Type
4.1 Global Levonorgestrel Historic Market Review by Type (2015-2020)
4.1.1 Global Levonorgestrel Sales Market Share by Type (2015-2020)
4.1.2 Global Levonorgestrel Revenue Market Share by Type (2015-2020)
4.1.3 Global Levonorgestrel Price by Type (2014-2020)
4.2 Global Levonorgestrel Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Levonorgestrel Sales Forecast by Type (2021-2026)
4.2.2 Global Levonorgestrel Revenue Forecast by Type (2021-2026)
4.2.3 Global Levonorgestrel Price Forecast by Type (2021-2026)
5 Global Levonorgestrel Market Size by Application
5.1 Global Levonorgestrel Historic Market Review by Application (2015-2020)
5.1.1 Global Levonorgestrel Sales Market Share by Application (2015-2020)
5.1.2 Global Levonorgestrel Revenue Market Share by Application (2015-2020)
5.1.3 Global Levonorgestrel Price by Application (2015-2020)
5.2 Global Levonorgestrel Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Levonorgestrel Sales Forecast by Application (2021-2026)
5.2.2 Global Levonorgestrel Revenue Forecast by Application (2021-2026)
5.2.3 Global Levonorgestrel Price Forecast by Application (2021-2026)

3 North America Levonorgestrel Market Facts & Figures
3.2 North America Levonorgestrel Sales Market Share by Company (2015-2020)
3.3 North America Levonorgestrel Sales Market Share by Type (2015-2020)
3.4 North America Levonorgestrel Sales Market Share by Application (2015-2020)

4 Europe Levonorgestrel Market Facts & Figures
4.2 Europe Levonorgestrel Sales Market Share by Company (2015-2020)
4.3 Europe Levonorgestrel Sales Market Share by Type (2015-2020)
4.4 Europe Levonorgestrel Sales Market Share by Application (2015-2020)

5 China Levonorgestrel Market Facts & Figures
5.2 China Levonorgestrel Sales Market Share by Company (2015-2020)
5.3 China Levonorgestrel Sales Market Share by Type (2015-2020)
5.4 China Levonorgestrel Sales Market Share by Application (2015-2020)

6 Japan Levonorgestrel Market Facts & Figures
6.2 Japan Levonorgestrel Sales Market Share by Company (2015-2020)
6.3 Japan Levonorgestrel Sales Market Share by Type (2015-2020)
6.4 Japan Levonorgestrel Sales Market Share by Application (2015-2020)

7 Southeast Asia Levonorgestrel Market Facts & Figures
7.2 Southeast Asia Levonorgestrel Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Levonorgestrel Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Levonorgestrel Sales Market Share by Application (2015-2020)

8 India Levonorgestrel Market Facts & Figures
8.2 India Levonorgestrel Sales Market Share by Company (2015-2020)
8.3 India Levonorgestrel Sales Market Share by Type (2015-2020)
8.4 India Levonorgestrel Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Levonorgestrel Business
12.1 Bayer
12.1.1 Bayer Levonorgestrel Corporation Information
12.1.2 Bayer Levonorgestrel Business Overview and Total Revenue
12.1.3 Bayer Levonorgestrel Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer Levonorgestrel Products Offered
12.1.5 Bayer Recent Development
12.2 Paladin Labs
12.2.1 Paladin Labs Levonorgestrel Corporation Information
12.2.2 Paladin Labs Levonorgestrel Business Overview and Total Revenue
12.2.3 Paladin Labs Levonorgestrel Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Paladin Labs Levonorgestrel Products Offered
12.2.5 Paladin Labs Recent Development
12.3 Foundation Consumer Healthcare
12.3.1 Foundation Consumer Healthcare Levonorgestrel Corporation Information
12.3.2 Foundation Consumer Healthcare Levonorgestrel Business Overview and Total Revenue
12.3.3 Foundation Consumer Healthcare Levonorgestrel Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Foundation Consumer Healthcare Levonorgestrel Products Offered
12.3.5 Foundation Consumer Healthcare Recent Development
12.4 Theramex (Teva)
12.4.1 Theramex (Teva) Levonorgestrel Corporation Information
12.4.2 Theramex (Teva) Levonorgestrel Business Overview and Total Revenue
12.4.3 Theramex (Teva) Levonorgestrel Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Theramex (Teva) Levonorgestrel Products Offered
12.4.5 Theramex (Teva) Recent Development
12.5 Pfizer
12.5.1 Pfizer Levonorgestrel Corporation Information
12.5.2 Pfizer Levonorgestrel Business Overview and Total Revenue
12.5.3 Pfizer Levonorgestrel Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer Levonorgestrel Products Offered
12.5.5 Pfizer Recent Development
12.6 Apotex
12.6.1 Apotex Levonorgestrel Corporation Information
12.6.2 Apotex Levonorgestrel Business Overview and Total Revenue
12.6.3 Apotex Levonorgestrel Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Apotex Levonorgestrel Products Offered
12.6.5 Apotex Recent Development
12.7 HRA Pharma
12.7.1 HRA Pharma Levonorgestrel Corporation Information
12.7.2 HRA Pharma Levonorgestrel Business Overview and Total Revenue
12.7.3 HRA Pharma Levonorgestrel Sales, Revenue and Gross Margin (2015-2020)
12.7.4 HRA Pharma Levonorgestrel Products Offered
12.7.5 HRA Pharma Recent Development

13 Levonorgestrel Manufacturing Cost Analysis
13.1 Levonorgestrel Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Levonorgestrel
13.4 Levonorgestrel Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Levonorgestrel Distributors List
14.3 Levonorgestrel Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Levonorgestrel Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Levonorgestrel Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Levonorgestrel Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Levonorgestrel Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Levonorgestrel Players to Combat Covid-19 Impact
Table 8. Global Market Levonorgestrel Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Levonorgestrel Sales (K Units) by Region (2015-2020)
Table 10. Global Levonorgestrel Sales Market Share by Region (2015-2020)
Table 11. Global Levonorgestrel Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Levonorgestrel Revenue Share by Region (2015-2020)
Table 13. Global Levonorgestrel Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Levonorgestrel Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Levonorgestrel Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Levonorgestrel Revenue Share Forecast by Region (2021-2026)
Table 17. Global Levonorgestrel (K Units) of Key Companies (2015-2020)
Table 18. Global Levonorgestrel Sales Share by Company (2015-2020)
Table 19. Global Levonorgestrel Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Levonorgestrel Revenue Share by Company (2015-2020)
Table 21. Global Levonorgestrel by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Levonorgestrel as of 2019)
Table 22. Global Levonorgestrel Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Levonorgestrel Manufacturing Sites and Area Served
Table 24. Manufacturers Levonorgestrel Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Levonorgestrel Players
Table 27. Global Levonorgestrel Sales (K Units) by Type (2015-2020)
Table 28. Global Levonorgestrel Sales Share by Type (2015-2020)
Table 29. Global Levonorgestrel Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Levonorgestrel Price (K Units) by Type (2015-2020)
Table 31. Global Levonorgestrel Sales Share by Type (2021-2026)
Table 32. Global Levonorgestrel Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Levonorgestrel Revenue Share by Type (2021-2026)
Table 34. Global Levonorgestrel Price (K Units) by Type (2021-2026)
Table 35. Global Levonorgestrel Sales (K Units) by Application (2015-2020)
Table 36. Global Levonorgestrel Sales Share by Application (2015-2020)
Table 37. Global Levonorgestrel Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Levonorgestrel Price (K Units) by Application (2015-2020)
Table 39. Global Levonorgestrel Sales (K Units) by Application (2021-2026)
Table 40. Global Levonorgestrel Sales Share by Application (2021-2026)
Table 41. Global Levonorgestrel Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Levonorgestrel Revenue Share by Application (2021-2026)
Table 43. Global Levonorgestrel Price (K Units) by Application (2021-2026)
Table 44. United States Levonorgestrel Sales (K Units) by Company (2015-2020)
Table 45. United States Levonorgestrel Sales Market Share by Company (2015-2020)
Table 46. United States Levonorgestrel Sales (K Units) by Type (2015-2020)
Table 47. United States Levonorgestrel Sales Market Share by Type (2015-2020)
Table 48. United States Levonorgestrel Sales (K Units) by Application (2015-2020)
Table 49. United States Levonorgestrel Sales Market Share by Application (2015-2020)
Table 50. Europe Levonorgestrel Sales (K Units) by Company (2015-2020)
Table 51. Europe Levonorgestrel Sales Market Share by Company (2015-2020)
Table 52. Europe Levonorgestrel Sales (K Units) by Type (2015-2020)
Table 53. Europe Levonorgestrel Sales Market Share by Type (2015-2020)
Table 54. Europe Levonorgestrel Sales (K Units) by Application (2015-2020)
Table 55. Europe Levonorgestrel Sales Market Share by Type (2015-2020)
Table 56. China Levonorgestrel Sales (K Units) by Company (2015-2020)
Table 57. China Levonorgestrel Sales Market Share by Company (2015-2020)
Table 58. China Levonorgestrel Sales (K Units) by Type (2015-2020)
Table 59. China Levonorgestrel Sales Market Share by Type (2015-2020)
Table 60. China Levonorgestrel Sales (K Units) by Application (2015-2020)
Table 61. China Levonorgestrel Sales Market Share by Application (2015-2020)
Table 62. Japan Levonorgestrel Sales (K Units) by Company (2015-2020)
Table 63. Japan Levonorgestrel Sales Market Share by Company (2015-2020)
Table 64. Japan Levonorgestrel Sales (K Units) by Type (2015-2020)
Table 65. Japan Levonorgestrel Sales Market Share by Type (2015-2020)
Table 66. Japan Levonorgestrel Sales (K Units) by Application (2015-2020)
Table 67. Japan Levonorgestrel Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Levonorgestrel Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Levonorgestrel Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Levonorgestrel Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Levonorgestrel Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Levonorgestrel Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Levonorgestrel Sales Market Share by Application (2015-2020)
Table 74. India Levonorgestrel Sales (K Units) by Company (2015-2020)
Table 75. India Levonorgestrel Sales Market Share by Company (2015-2020)
Table 76. India Levonorgestrel Sales (K Units) by Type (2015-2020)
Table 77. India Levonorgestrel Sales Market Share by Type (2015-2020)
Table 78. India Levonorgestrel Sales (K Units) by Application (2015-2020)
Table 79. India Levonorgestrel Sales Market Share by Application (2015-2020)
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Levonorgestrel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Bayer Levonorgestrel Product
Table 84. Bayer Recent Development
Table 85. Paladin Labs Corporation Information
Table 86. Paladin Labs Description and Business Overview
Table 87. Paladin Labs Levonorgestrel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Paladin Labs Levonorgestrel Product
Table 89. Paladin Labs Recent Development
Table 90. Foundation Consumer Healthcare Corporation Information
Table 91. Foundation Consumer Healthcare Description and Business Overview
Table 92. Foundation Consumer Healthcare Levonorgestrel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Foundation Consumer Healthcare Levonorgestrel Product
Table 94. Foundation Consumer Healthcare Recent Development
Table 95. Theramex (Teva) Corporation Information
Table 96. Theramex (Teva) Description and Business Overview
Table 97. Theramex (Teva) Levonorgestrel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Theramex (Teva) Levonorgestrel Product
Table 99. Theramex (Teva) Recent Development
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Levonorgestrel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Pfizer Levonorgestrel Product
Table 104. Pfizer Recent Development
Table 105. Apotex Corporation Information
Table 106. Apotex Description and Business Overview
Table 107. Apotex Levonorgestrel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Apotex Levonorgestrel Product
Table 109. Apotex Recent Development
Table . HRA Pharma Corporation Information
Table . HRA Pharma Description and Business Overview
Table . HRA Pharma Levonorgestrel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . HRA Pharma Levonorgestrel Product
Table . HRA Pharma Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Levonorgestrel Distributors List
Table 118. Levonorgestrel Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Levonorgestrel Product Picture
Figure 2. Global Levonorgestrel Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Levonorgestrel Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Drug Store Examples
Figure 8. Online Sale Examples
Figure 9. Global Levonorgestrel Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Levonorgestrel Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Levonorgestrel Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Levonorgestrel Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Levonorgestrel Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Levonorgestrel Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Levonorgestrel Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Levonorgestrel Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Levonorgestrel Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Levonorgestrel Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Levonorgestrel Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Levonorgestrel Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Levonorgestrel Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Levonorgestrel Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Levonorgestrel Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Levonorgestrel Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Levonorgestrel Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Levonorgestrel Players Market Share by Revenue in Levonorgestrel 2015 & 2019
Figure 27. Levonorgestrel Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Levonorgestrel Revenue Share by Type (2015-2020)
Figure 29. Global Levonorgestrel Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Levonorgestrel Revenue Share by Application (2015-2020)
Figure 31. Global Levonorgestrel Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Levonorgestrel Sales Market Share by Type in 2019
Figure 33. United States Levonorgestrel Sales Market Share by Type in 2019
Figure 34. Europe Levonorgestrel Sales Market Share by Company in 2019
Figure 35. Europe Levonorgestrel Sales Market Share by Type in 2019
Figure 36. Europe Levonorgestrel Sales Market Share by Application in 2019
Figure 37. China Levonorgestrel Sales Market Share by Company in 2019
Figure 38. China Levonorgestrel Sales Market Share by Type in 2019
Figure 39. China Levonorgestrel Sales Market Share by Application in 2019
Figure 40. Japan Levonorgestrel Sales Market Share by Company in 2019
Figure 41. Japan Levonorgestrel Sales Market Share by Type in 2019
Figure 42. Japan Levonorgestrel Sales Market Share by Application in 2019
Figure 43. Southeast Asia Levonorgestrel Sales Market Share by Company in 2019
Figure 44. Southeast Asia Levonorgestrel Sales Market Share by Type in 2019
Figure 45. Southeast Asia Levonorgestrel Sales Market Share by Application in 2019
Figure 46. India Levonorgestrel Sales Market Share by Company in 2019
Figure 47. India Levonorgestrel Sales Market Share by Type in 2019
Figure 48. India Levonorgestrel Sales Market Share by Application in 2019
Figure 49. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Paladin Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Foundation Consumer Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Theramex (Teva) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. HRA Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Levonorgestrel
Figure 58. Manufacturing Process Analysis of Levonorgestrel
Figure 59. Levonorgestrel Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed